team
A team of experts to tackle challenges in inhalation drug delivery
Board of directors
Elijah Nazarzadeh
Co-founder & CSO
Dr. Elijah Nazarzadeh has led Nebu-Flow®’s technology and business development through his postdoctoral research at the University of Glasgow. Elijah started the business development by securing an Innovate UK’s ICURe programme and was subsequently awarded an Unlocking Ambition Fellowship, supported by the Scottish Government, from the Royal Society of Edinburgh.
John Pritchard
Chairman
Dr. John Pritchard has more than 25 years of experience in the field working for GSK, AstraZeneca, 3M and Philips. He received the Charles Thiel Award from Virginia Commonwealth University for outstanding research and discovery in respiratory drug delivery in 2018.
Andrea Cusack
CEO
Prior to joining Nebuflow in 2024, Andrea previously served as CEO for leon-nanodrugs GmbH, and in a variety of roles for GSK, Catalent, West Pharma and small technology startups. Andrea holds a degree in Chemistry and Engineering from Cardiff University and has over 25 years of experience in commercial arrangements, M&A activity and fund raising within the Life Science sectors. She is committed to value creation through entrepreneurship and innovation, prioritising the ultimate benefit to patients.
Max McGowan
Fractional CFO
Max is a highly experienced Finance Director/CFO and business leader with a broad range of financial management, accounting, operational, legal, M&A, corporate finance, commercial and project management experience. Max has worked across a range of startup, high growth and PE backed businesses in a variety of sectors, from start up, through growth phases and to exit.
Duncan Thorburn
Director
Duncan is an Investment Manager at Foresight Group. Prior to joining Foresight, Duncan worked in corporate finance assisting SMEs with M&A and fundraising mandates, with a focus in the tech sector. Duncan is a qualified Chartered Accountant with the Institute of Chartered Accountants Scotland and holds an MA in Business Studies and Accounting from the University of Edinburgh.
Dr Harry Destecroix
Director
Harry is the founder of the Science Creates ecosystem and Managing Partner of Science Creates Ventures. He is a scientist, entrepreneur and investor, and the co-founder of Ziylo, the hugely successful University of Bristol spin-out company. Harry is passionate about building great companies and providing the optimum ecosystem to facilitate their growth and development.
Prof. Jon Cooper
Director
Professor Cooper has already spun successful companies from his research, including Mode-Dx (who signed an agreement with Boots covering bowel cancer diagnostics) and Clyde Biosciences (developing drug screening with three pharmaceutical companies).
Dr. Mike Khan
Director
Dr. Mike Khan has over 25 years of experience as a leader in R&D, spanning the full spectrum of preclinical, translational and clinical development. He blends deep siRNA domain knowledge with clinical experience and has taken siRNA drugs through IND to design and completion of Phase 2.
Advisory Board
Dr. Gary Pitcairn
Advisor
Dr Gary Pitcairn is an experienced senior leader, with a successful track record of leading global multidisciplinary teams. Gary is a recognised expert in the field of inhaled drug delivery with extensive device experience in both nebulisers and inhalers. Gary also has proven product development experience, from pre-clinical through to late phase.
Dr. Helen Erwood
Regulatory Advisor
Dr. Helen Erwood, Director of ESPL, has nearly 30 years of experience in regulatory affairs working for ICI Pharmaceuticals (now Astra-Zeneca), Rhone Poulenc Rorer (now Sanofi Aventis) and SmithKline Beecham Consumer Healthcare (now GSK Consumer).
Dr. Helen Muirhead FRSC
Advisor
Dr. Helen Muirhead is a Fellow of the Royal Society of Chemistry with 42 years of experience of both R&D and Manufacturing, including 30 years at GSK. Helen headed up the Respiratory Centre of Excellence during the late stages of Product Development through Regulatory Filing and Commercial Launch and supply of new Medicines.
Dr. Julien Reboud
Scientific Advisor
Dr. Julien Reboud, a co-founder of Nebu-Flow®, is Senior Lecturer at the University of Glasgow. He is joint winner of the Royal Academy of Engineering ERA Foundation Entrepreneurs Award. Julien brings a long track record of research and application of the SAW technology.
Prof. Dr. Gordon Muirhead GSK Emeritus Senior Fellow
Advisor
Prof. Dr. Gordon Muirhead has more than 20 years of experience in senior roles at GlaxoSmithKline (GSK) including 12 years as Vice President of Global New Medicines Introduction within the Global Manufacturing and Supply division of GSK.
In office team
Christian Witte
Lead Scientist
David Tatnell
Acoustic Scientist
Duncan Finlayson
Lead Mechanical Engineer
Gavin Anderson
Electronic Engineer
Graham Matthews
Business Development Officer
Habib Nassar
Electronic Engineer
Ivona Ivanova
Graduate Engineer
Jeanne Michalon
Design Engineer
Kiing (KS) Seng Wong
Acoustic Scientist
Neil Fullarton
Laboratory Technician
Prince Hugo
Wellbeing officer
Rabeeah Habib
Fluid Mechanic Scientist
Sarina Saeidi
Laboratory Technician
Stacey Latham
Executive Assistant/Office Manager
Our culture
We are Nebu~Flow®
Our people are passionate about the development of products with a positive impact on the lives of patients, whilst considering sustainability and the future of our planet at the heart of our activities. We are a diverse and knowledgeable team, focused on patient-centric healthcare and creating innovative products to address the need of both healthcare systems and the pharmaceutical industry. Moreover, we are committed to establishing an inclusive workspace that values everyone equally.
